Unicycive Therapeutics (UNCY) EPS (Basic) (2020 - 2026)
Unicycive Therapeutics' (UNCY) quarterly EPS (Basic) came in at -$0.54 in Q1 2026, down 1328.63% YoY from $0.04 in Q1 2025, and down 32.24% on a QoQ basis from -$0.41 in Q4 2025.
Unicycive Therapeutics (UNCY) EPS (Basic) (2020 - 2026) Analysis & Trends
Unicycive Therapeutics (UNCY) has 7 years of EPS (Basic) data on file, last reported at -$0.54 in Q1 2026.
- Quarterly EPS (Basic) fell 1328.63% year-over-year to -$0.54 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.33 (up 29.75% YoY) and the FY2025 annual result came in at -$3.41, up 39.61% from the prior year.
- EPS (Basic) declined to -$0.54 in Q1 2026, from -$0.41 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.8 in Q2 2024 to a low of -$9.69 in Q1 2023.
- A 5-year average of -$2.34 and a median of -$2.36 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) soared 127.53% — and 2026, when it plunged 1328.63%.
- Tracing UNCY's EPS (Basic) over 5 years: stood at -$3.54 in 2022, then grew by 10.2% to -$3.18 in 2023, then declined by 1.12% to -$3.21 in 2024, then surged by 87.38% to -$0.41 in 2025, then plunged by 32.24% to -$0.54 in 2026.
- The last three EPS (Basic) figures came in at -$0.54 (Q1 2026), -$0.41 (Q4 2025), and -$0.33 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.23 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.06 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.18 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -0.72 |
| 10 | Unicycive Therapeutics | 147.24 Mn | 147.24 Mn | - | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07 |
| Mar 31, 2026 | -0.54 |
| Dec 31, 2025 | -0.41 |
| Sep 30, 2025 | -0.33 |
| Jun 30, 2025 | -0.52 |
| Mar 31, 2025 | 0.04 |
| Dec 31, 2024 | -3.21 |
| Sep 30, 2024 | -0.46 |
| Jun 30, 2024 | 0.80 |
| Mar 31, 2024 | -6.06 |
| Dec 31, 2023 | -3.18 |
| Sep 30, 2023 | -1.35 |
| Jun 30, 2023 | -2.92 |
| Mar 31, 2023 | -9.69 |
| Dec 31, 2022 | -3.54 |
| Sep 30, 2022 | -3.69 |
| Jun 30, 2022 | -2.42 |
| Mar 31, 2022 | -2.36 |
| Dec 31, 2021 | -2.36 |
| Sep 30, 2021 | -3.67 |